Risk factor modification in stroke prevention: The experience of a stroke clinic

Stroke

Volumn 30, Issue 1, 1999, Pages 16-20

  Joseph, Lenore N ^a   Babikian, Viken L ^a,c   Allen, Nancy C ^a   Winter, Michael R ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Lifestyle; Risk factors; Stroke prevention

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CEREBROVASCULAR DISEASE; DIET THERAPY; EXERCISE; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 0032908499     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.1.16     Document Type: Article

References (34)

1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Stroke Unit Trialists' Collaboration. Collaborative systematic review of the randomized trials of organized inpatient (stroke unit) care after stroke. BMJ. 1997;314:1151-1159.
3. Stroke Unit Trialists' Collaboration. How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke. 1997;28:2139-2144.
4. Zivin JA. Neuroprotective therapies in stroke. Drugs. 1997;54(suppl 3):S83-S88.
5. Broderick JP. Logistics in acute stroke management. Drugs. 1997; 54(suppl 3):S109-S116.
6. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizibash N., Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease, 2: short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet. 1990;335:827-838.
7. MacMahon S. Blood pressure and the prevention of stroke. J Hypertens Suppl. 1996;14:839-546.
8. Wolf PA, Abbot RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22:983-988.
9. Wolf PA, D'Agostino RB, Kannel WB. Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham study. JAMA. 1988;259:1025-1029.
10. Iso H, Jacobs DR Jr, Wentworth D, Newton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med. 1989;320:904-910.
11. Hachinski V, Graffagnino C, Beaudry M, Bernier G, Buck C, Donner A, Spence JD, Doig G, Wolfe BMJ. Lipids and stroke: a paradox resolved. Arch Neurol. 1996;53:303-308.
12. Gorelick PB, Schneck M, Berglund LF, Feinberg W, Goldstone J. Status of lipids as a risk factor for stroke. Neuroepidemiology. 1997;16:107-115.
13. Burchfiel CM, Curb JD, Rodriguez BL, Abbott RD, Chiu D, Yano K. Glucose intolerance and 22-year stroke incidence: the Honolulu Heart Program. Stroke. 1994;25:951-957.
14. Jones DW. Body weight and blood pressure: effects of weight reduction on hypertension. Am J Hypertens. 1996;9:S50-S54.
15. Su HY, Sheu WH, Chin HM, Jeng CY, Chen YD, Reaven GM. Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals. Am J Hypertens. 1995;8:1067-1071.
16. Joseph L, Kase C, Beiser A, Wolf PA. Mild blood pressure elevation and stroke: the Framingham study. Stroke. 1998;28:277. Abstract.
17. JNC V. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1993;153:154-183.
18. US Department of Agriculture and US Department of Health and Human Services. Nutrition and Your Health: Dietary Guidelines for Americans. 4th ed. Washington, DC: US Government Printing Office; 1995. Home and Garden Bulletin 232.
19. Expert Panel. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med. 1988;148:36-69.
20. Adult Treatment Panel II. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 1993;269:3015-3023.
21. Hunninghake DB. Diagnosis and treatment of lipid disorders. Med Clin North Am. 1984;78:247-257.
22. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension. 1995; 26:60-69.
23. Sacco RL, Shi T, Zamanillo MC. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology. 1994;44:626-634.
24. Hier DB, Foulkes MA, Swiontoniowski M, Sacco RL, Gorelick PB, Mohr JP, Price TR, Wolf PA. Stroke recurrence within two years after ischemic infarction. Stroke. 1991;22:155-161.
25. Steptoe A, Wardle J. What the experts think: a European survey of expert opinion about the influence of lifestyle on health. Eur J Epidemiol. 1994;10:195-203.
26. Fahey T, Silagy C. General practitioners' knowledge of and attitudes to the management of hypertension in elderly patients. Br J Gen Pract. 1994;44:446-449.
27. Elford RW, Jennett P, Bell N, Szafran O, Meadows L. Putting prevention into practice. Health Rep. 1994;6:142-153.
28. McAlister FA, Laupacis A, Teo KK, Hamilton PG, Montague TJ. A survey of clinician attitudes and management practices in hypertension. J Hum Hypertens. 1997;11:413-419.
29. Ford GA, Asghar MN. Management of hypertension in the elderly: attitudes of general practitioners and hospital physicians. Br J Clin Pharmacol. 1995;39:465-469.
30. Lip GY, Beevers DG. Doctors, nurses, pharmacists and patients: the Rational Evaluation and Choice in Hypertension (REACH) survey of hypertension care delivery. Blood Press Suppl. 1997;1:S6-S10.
31. Gorelick PB. Stroke prevention: windows of opportunity and failed expectations? A discussion of modifiable cardiovascular risk factors and a prevention proposal. Neuroepidemiology. 1997;16:163-173.
32. Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med. 1980;303:1038-1041.
33. Thornton A, Lee P. Fry J. Differences between smokers, ex-smokers, passive smokers and non-smokers. J Clin Epidemiol. 1994;47:1143-1162.
34. Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J, Torgerson J, Carey K. A telecommunications system for monitoring and counseling patients with hypertension: impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9:285-292.